CONTENTS Foreword
Preface
Contributors
Section I: General, Identity and Taxonomy
1. The genus Phoma: What we know and what we need to know?
Mahendra Rai, Beata Zimowska, and György János Kövics
2. Taxonomical evaluation of Phoma- history of classification, current status
and future directions.
Beata Zimowska
Section II: Diversity, Diseases and Host Range
3. Phoma on medicinal and aromatic plants
Beata Zimowska
4. Diseases of fruits, tubers, and seeds caused by Phoma sensu lato species complex
Graciela Dolores Avila-Quezada and Mahendra Rai
5. Overview of Phoma-like fungi on important legumes (Papilionaceous plants)
György J. Kövics, László Irinyi, and Mahendra Rai
6. Diseases of vegetables caused by Phoma spp.
Farjana Sultana and Md. Motaher Hossain
7. Phoma diseases: identification, epidemiology and strategies for management
Omar Atik
8. Major plant diseases caused by Phoma sensu lato species and their integrated management strategies
Fatemeh Salmaninezhad, Reza Mostowfizadeh-Ghalamfarsa, and
Santa Olga Maria Cacciola
9. Phoma as an infectious pathogen in medical practice
Elena V. Kukhar, and Vladimir S. Kiyan
Section III: Secondary metabolites and Bioactivities
10. Fruitful decade of Phoma secondary metabolites from 2011 to 2020: Chemistry, chemical diversity and biological activities
Hidayat Hussain, Elizbit, Iftikhar Ali, Nilufar Z. Mamadalieva, Ghulam Abbas, Maroof Ali, Gohar Zaman, Amjad Khan, Uzma Hassan, Ivan R. Green
11. Bioactive secondary metabolites from endophytic Phoma spp
Pramod Kumar Mahish, Shweta Singh and Ravishankar Chauhan
12. The genus Phoma: a review of its potential bioactivities, implications and prospects
Luciana Luft, Tássia C. Confortin, Izelmar Todero, Marcio A. Mazutti
13. Bioherbicidal
About the Author:
Professor Mahendra Rai is a Basic Science Research Faculty Fellow at Department of Biotechnology, Sant Gadge Baba Amravati University in Maharashtra, India. He has published more than 400 research publications, 100 popular articles in journals of high repute and 60 books from reputed publishers. He has received several prestigious awards, including the father T.A. Mathias award from the All-India Association for Christian Higher Education, and the Medini award from the Department of Environment and Forest, Government of India. He also received SERC visiting fellowship by Department of Science and Technology, INSA visiting fellowship by Indian National Science Academy and TWAS-UNESCO Associateship, Italy. Dr. Rai serves as a referee for more than 20 international journals and is associate editor/ member of editorial board of more than ten national and international journals. He has approximately three decades of teaching and research experience. The main focus of his research is nanobiotechnology and nano based bioactive against human pathogenic microbes.
Ivan Kosalec, a tenured scientific advisor, holds a professorship at the University of Zagreb, Faculty of Pharmacy and Biochemistry. Since Croatia's accession to the EU (2013), he has served as a Croatian delegate to the European Medicines Agency (EMA) in the HMPC Committee. He is also an external expert for the Croatian Medicines and Medical Devices Agency and a member of the interdisciplinary section of the Ministry of Health for Antibiotic Resistance Control (ISKRA). The main focus of his scientific work is in the field of virulence inhibition of medically important yeasts and determination of in vitro antimicrobial activity of compounds of synthetic and natural origin. He has published more than 100 scientific papers in peer-reviewed journals. Dr Ivan Kosalec has participated in several European and national projects mainly dealing with the identification of microbial species and the antimicrobial activity of substances of different origins (nanomaterials, botanicals, de novo synthesised molecules, etc.). As an active referee, he is also a member of the international editorial board in three scientific journals (Molecules, Archives of Occupational Hygiene and Toxicology). Dr I. Kosalec received the Diploma - Distinction from Croatian Pharmaceutical Society in 2017.
